淀粉样变心肌病对目前的心衰治疗多无反应，其中位生存期小于6个月，5年存活率小于10%。

Amyloid cardiomyopathy is largely unresponsive to current heart failure therapies and is associated with a median survival of less than 6 months and a 5-year survival of less than 10%.

youdao

淀粉样变心肌病对目前的心衰治疗多无反应，其中位生存期小于6个月，5年存活率小于10%。

Amyloid cardiomyopathy is largely unresponsive to current heart failure therapies and is associated with a median survival of less than 6 months and a 5-year survival of less than 10%.

youdao